These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17373558)

  • 1. Arginine deiminases: therapeutic tools in the etiology and pathogenesis of Alzheimer's disease.
    Louw C; Gordon A; Johnston N; Mollatt C; Bradley G; Whiteley CG
    J Enzyme Inhib Med Chem; 2007 Feb; 22(1):121-6. PubMed ID: 17373558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides.
    Mohlake P; Whiteley CG
    Mol Neurobiol; 2010 Jun; 41(2-3):149-58. PubMed ID: 20224908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine metabolising enzymes as targets against Alzheimers' disease.
    Whiteley CG
    Neurochem Int; 2014 Feb; 67():23-31. PubMed ID: 24508404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
    Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
    J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
    Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
    J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of PAD2 after repeated intracerebroventricular infusions of soluble Abeta(25-35) in the Alzheimer's disease model rat brain: effect of memantine.
    Arif M; Kato T
    Cell Mol Biol Lett; 2009; 14(4):703-14. PubMed ID: 19641855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d-enantiomeric peptide.
    Jiang N; Frenzel D; Schartmann E; van Groen T; Kadish I; Shah NJ; Langen KJ; Willbold D; Willuweit A
    Biochim Biophys Acta; 2016 Nov; 1858(11):2717-2724. PubMed ID: 27423267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease.
    Larner AJ
    Neurobiol Aging; 1999; 20(1):65-9. PubMed ID: 10466895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of drugs for Alzheimer's disease.
    Sun X; Jin L; Ling P
    Drug Discov Ther; 2012 Dec; 6(6):285-90. PubMed ID: 23337815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation of Lys-16 and Arg-5 in amyloid-β and the presence of Cu
    Fica-Contreras SM; Shuster SO; Durfee ND; Bowe GJK; Henning NJ; Hill SA; Vrla GD; Stillman DR; Suralik KM; Sandwick RK; Choi S
    J Biol Inorg Chem; 2017 Dec; 22(8):1211-1222. PubMed ID: 29038915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
    Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA
    Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
    Lee HG; Castellani RJ; Zhu X; Perry G; Smith MA
    Int J Exp Pathol; 2005 Jun; 86(3):133-8. PubMed ID: 15910547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
    Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
    Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.